These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 8713413)

  • 1. [The use of perftoran in clinical medicine].
    Moroz VV; Kruylov NL; Ivanitskii GR; Kaidash AN; Onishchenko NA; Simanov VA; Vorob'ev SI
    Anesteziol Reanimatol; 1995; (6):12-7. PubMed ID: 8713413
    [No Abstract]   [Full Text] [Related]  

  • 2. [Properties and clinical use of perfluorocarbons].
    Kościelak J; Scharf R
    Acta Haematol Pol; 1986; 17(1-2):56-62. PubMed ID: 3535344
    [No Abstract]   [Full Text] [Related]  

  • 3. Perfluorocarbon compounds.
    Faithfull NS; Weers JG
    Vox Sang; 1998; 74 Suppl 2():243-8. PubMed ID: 9704451
    [No Abstract]   [Full Text] [Related]  

  • 4. Perfluorochemical "blood substitutes".
    Tremper KK
    Anesthesiology; 1999 Nov; 91(5):1185-7. PubMed ID: 10551564
    [No Abstract]   [Full Text] [Related]  

  • 5. Blood substitutes as therapy in massive surgery and trauma.
    Tye RW
    Prog Clin Biol Res; 1982; 108():79-89. PubMed ID: 6817339
    [No Abstract]   [Full Text] [Related]  

  • 6. [Clinical use of the fluorocarbon blood substitute perfluoran].
    Krylov NL; Moroz VV; Beloiartsev FF
    Voen Med Zh; 1985 Aug; (8):36-40. PubMed ID: 3904195
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical potential of intravenously administered perfluorocarbons.
    Habler O; Kleen M; Messmer K
    Acta Anaesthesiol Scand Suppl; 1997; 111():256-8. PubMed ID: 9421036
    [No Abstract]   [Full Text] [Related]  

  • 8. [Biophysics at the turn of the new millenium: perfluorocarbon media and gas-transporting blood substitutes].
    Ivanitskiĭ GR
    Biofizika; 2001; 46(1):5-33. PubMed ID: 11236562
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Perftoran in complex therapy of acute myocardial infarction in elderly patients].
    Abusuev AA
    Adv Gerontol; 2008; 21(4):670-5. PubMed ID: 19432223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The use of perftoran in patients with burn shock].
    Kligunenko EN; Slinchenkov VV; Leshchev DP
    Klin Khir; 2000; (4):41-3. PubMed ID: 10857343
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blood substitutes in surgery.
    Burris D
    Ann Chir Gynaecol; 2001; 90(2):76-80. PubMed ID: 11459262
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Artificial blood substitutes.
    Schneider P
    Transfus Sci; 1992 Jul; 13(3):357-70. PubMed ID: 10148132
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical results of the application of perftoran for the treatment of odontogenous abcesses and phlegmons in the maxillofacial region.
    Durnovo EA; Furman IV; Pushkin SY; Maslennikov IA; Bondar OG; Ivanitsky GR
    J Craniomaxillofac Surg; 2008 Apr; 36(3):161-172. PubMed ID: 18353665
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Which is the foreseeable clinical application of oxygen-carrying blood substitutes (fluorocarbons and hemoglobin solutions)? Which impact are they likely to have on the activity of blood services?
    Vox Sang; 1982 Feb; 42(2):97-109. PubMed ID: 7064434
    [No Abstract]   [Full Text] [Related]  

  • 15. Use of perftoran emulsion to decrease allogeneic blood transfusion in cardiac surgery: clinical trial.
    Verdin-Vasquez RC; Zepeda-Perez C; Ferra-Ferrer R; Chavez-Negrete A; Contreras F; Barroso-Aranda J
    Artif Cells Blood Substit Immobil Biotechnol; 2006; 34(4):433-54. PubMed ID: 16818416
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Blood coagulation in dogs following the compensation of acute blood loss with polyglucin and an emulsion of perfluoro compounds].
    Panchenko SM; Afonin NI
    Gematol Transfuziol; 1988 May; 33(5):29-31. PubMed ID: 2457535
    [No Abstract]   [Full Text] [Related]  

  • 17. [Perftoran--blood substitute with oxygen transport function].
    Golubev AM
    Biull Eksp Biol Med; 1998 May; 125(5):484-92. PubMed ID: 9644539
    [No Abstract]   [Full Text] [Related]  

  • 18. [Results of the use of perftoran for anti-ischemic protection of renal transplant].
    Zakharov VV
    Klin Khir; 1997; (1):24-6. PubMed ID: 9254261
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Characteristics of the body oxygen supply when replacing blood loss of moderate severity with an emulsion of perfluoroorganic compounds and with polyglucin].
    Iarochkin VS; Volos OP; Koziner VB
    Gematol Transfuziol; 1986 Jun; 31(6):43-7. PubMed ID: 2426156
    [No Abstract]   [Full Text] [Related]  

  • 20. [Successive replacement of fatal blood loss in dogs with polyglucin and perfluorocarbon emulsion].
    Akhsianov UU; Afonin NI
    Biull Eksp Biol Med; 1984 Aug; 98(8):160-2. PubMed ID: 6205706
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.